Bimekizumab efficacy in male and female patients with axial spondyloarthritis: 52-week results from the Phase 3 BE MOBILE rials.

Bimzelx (bimekizumab-bkzx) - UCB

http://www.ncbi.nlm.nih.gov/pubmed/42605056

Atul Deodhar; Denis Poddubnyy; Irene E van der Horst-Bruinsma; Lianne S Gensler; Marina Magrey; Martin Rudwaleit; Natasha de Peyrecave; Sarah Kavanagh; Sofia Ramiro; Vanessa Taieb

Aug 18, 2026